These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 3668243)

  • 1. Renal haemodynamic studies in obesity hypertension.
    Reisin E; Messerli FG; Ventura HO; Frohlich ED
    J Hypertens; 1987 Aug; 5(4):397-400. PubMed ID: 3668243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in obese subjects: distinct hypertensive subgroup.
    Licata G; Scaglione R; Capuana G; Parrinello G; Di Vincenzo D; Mazzola G
    J Hum Hypertens; 1990 Feb; 4(1):37-41. PubMed ID: 2345385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function.
    Scaglione R; Ganguzza A; Corrao S; Parrinello G; Merlino G; Dichiara MA; Arnone S; D'Aubert MD; Licata G
    Int J Obes Relat Metab Disord; 1995 Jun; 19(6):403-9. PubMed ID: 7550525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and hemodynamic effects of medium-term ketanserin treatment in 2 compared groups of obese and non-obese hypertensive patients].
    Licata G; Scaglione R; Parrinello G; Capuana G; Mazzola G; Lipari R; Galantino L; Castello R
    G Clin Med; 1989 Oct; 70(10):597-603. PubMed ID: 2599284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regional hemodynamics of the forearm. Comparison between obese and non-obese hypertensive patients].
    Raison J; London G; Safar M
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():65-9. PubMed ID: 3142431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forearm haemodynamics in obese normotensive and hypertensive subjects.
    Raison JM; Safar ME; Cambien FA; London GM
    J Hypertens; 1988 Apr; 6(4):299-303. PubMed ID: 2967861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and hemodynamic effects of medium-term treatment with ketanserin of 2 comparative groups of obese and non-obese hypertensive patients].
    Parrinello G
    Ann Ital Med Int; 1990; 5(4 Pt 2):477-83. PubMed ID: 2102135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of acute haemodynamic response to high-dose naloxone in young hypertensive and normotensive humans.
    Hara K; Senn BM; Floras JS
    Clin Invest Med; 1995 Apr; 18(2):108-13. PubMed ID: 7788955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood antidiuretic activity and selected haemodynamic indicators in patients with essential hypertension.
    Shkhvatsabaya IK; Pershakova LP; Yurenev AP; Kramer AA; Ivanov YI; Orlovsky VF
    Cor Vasa; 1980; 22(1-2):74-84. PubMed ID: 7398348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exaggerated haemodynamic and neural responses to involuntary contractions induced by whole-body vibration in normotensive obese versus lean women.
    Dipla K; Kousoula D; Zafeiridis A; Karatrantou K; Nikolaidis MG; Kyparos A; Gerodimos V; Vrabas IS
    Exp Physiol; 2016 Jun; 101(6):717-30. PubMed ID: 27061448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does obesity influence early target organ damage in hypertensive patients?
    Schmieder RE; Messerli FH
    Circulation; 1993 May; 87(5):1482-8. PubMed ID: 8491003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamics of hypertensive animals.
    Iriuchijima J
    Int Rev Physiol; 1982; 26():51-86. PubMed ID: 7107153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
    Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between plasma angiotensinII, leptin and arterial blood pressure.
    Al-Hazimi AM; Syiamic AY
    Saudi Med J; 2004 Sep; 25(9):1193-8. PubMed ID: 15448764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma endothelin-1 is not increased in overweight/obese hypertensive African women.
    Schutte R; Huisman HW; Schutte AE; Malan NT
    Blood Press; 2005; 14(5):279-83. PubMed ID: 16257873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between obesity-related metabolic factors and vascular changes in early hypertension.
    Berglund G; Hellström A; Ljungman S; Hartford M; Wikstrand J
    J Hum Hypertens; 1987 Jun; 1(1):25-30. PubMed ID: 3508195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
    O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
    J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume and vasoconstriction in experimental renovascular hypertension.
    Freeman RH; Davis JO; Seymour AA
    Fed Proc; 1982 Jun; 41(8):2409-14. PubMed ID: 7044827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.